GSK Agreed To Settle California Zantac Litigation After Judge Cleared Plaintiff's Experts To Testify

State court judge would've allowed testimony from 13 of 14 witnesses plaintiff proposed as experts for trial scheduled to start in late July. Plaintiff’s attorneys said decision on experts “signals significant litigation on the horizon for GSK.”

A judge's decision to allow 13 plaintiff's witnesses to testify as experts may have swayed GSK plc to announce a settlement in litigation in California state court alleging the firm’s ranitidine-containing Zantac caused the plainitff's bladder cancer and the firm failed to warn of the cancer risk.

The UK pharma, which doesn’t market Zantac OTC in the US but developed and previously manufactured and marketed the heartburn...